Literature DB >> 11555666

Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy.

P Aaltonen1, P Luimula, E Aström, T Palmen, T Grönholm, E Palojoki, I Jaakkola, H Ahola, I Tikkanen, H Holthöfer.   

Abstract

Diabetic nephropathy is a major complication of diabetes leading to thickening of the glomerular basement membrane, glomerular hypertrophy, mesangial expansion, and overt renal disease. The pathophysiologic mechanisms of diabetic nephropathy remain poorly understood. Nephrin is a recently found podocyte protein crucial for the interpodocyte slit membrane structure and maintenance of an intact filtration barrier. Here we have assessed the role of nephrin in two widely used animal models of diabetes, the streptozotocin model of the rat and the nonobese diabetic mouse. In both models, the expression levels of nephrin-specific mRNA as determined by real-time quantitative polymerase chain reaction increased up to two-fold during several weeks of follow-up. Immunohistochemical stainings revealed nephrin also more centrally within the glomerular tuft along with its preferential site in podocytes. Interestingly, as detected by immunoblotting, nephrin protein was also found in the urine of streptozotocin-induced rats. We conclude that nephrin is connected to the early changes of diabetic nephropathy and thus may contribute to the loss of glomerular filtration function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555666     DOI: 10.1038/labinvest.3780332

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  32 in total

Review 1.  Antiproteinuric effect of RAS blockade: new mechanisms.

Authors:  Markus Lassila; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

2.  Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice.

Authors:  Pengxun Han; Mumin Shao; Lan Guo; Wenjing Wang; Gaofeng Song; Xuewen Yu; Chunlei Zhang; Na Ge; Tiegang Yi; Shunmin Li; Heng Du; Huili Sun
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 3.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

4.  A 100-kDa urinary protein is associated with insulin resistance in offspring of type 2 diabetic patients.

Authors:  A Pätäri; P Karhapää; H Taipale; U Salmenniemi; E Ruotsalainen; P Vanninen; H Holthöfer; M Laakso
Journal:  Diabetologia       Date:  2005-07-08       Impact factor: 10.122

5.  Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes.

Authors:  Eun Young Kim; Stuart E Dryer
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

Review 6.  Gene expression in diabetic nephropathy.

Authors:  Daniela Hohenadel; Fokko J van der Woude
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

7.  Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor.

Authors:  Masao Kakoki; Nobuyuki Takahashi; J Charles Jennette; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

8.  Local and systemic renin-angiotensin system participates in cardiopulmonary-renal interactions in monocrotaline-induced pulmonary hypertension in the rat.

Authors:  Eva Malikova; Kristina Galkova; Peter Vavrinec; Diana Vavrincova-Yaghi; Zuzana Kmecova; Peter Krenek; Jan Klimas
Journal:  Mol Cell Biochem       Date:  2016-06-25       Impact factor: 3.396

Review 9.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

10.  Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.

Authors:  Jisheng Zhang; Haiyan Fu; Yan Xu; Yunfei Niu; Xiaofei An
Journal:  J Nat Med       Date:  2016-06-02       Impact factor: 2.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.